Table 3. Concordance of mutation variants according to primary/secondary tumor site or histological component.
| PATIENT | Tumor site/component | GENE/MUTATION/VARIANTS | ||
|---|---|---|---|---|
| 1 | kidney | FGFR3 | VHL1 | PTEN |
| diaphragm | FGFR3 | VHL1 | PTEN | |
| 2 | kidney | VHL1 | MET | |
| lung | VHL1 | MET | ||
| 3 | adrenal gland | |||
| kidney | ||||
| 6 | kidney | |||
| pancreas | ||||
| 7 | kidney | JAK3 | ||
| lung | JAK3 | |||
| 13 | kidney (rhadboid) | EGFR | RB1 | |
| liver | PTEN | |||
| 15 | kidney (rhadboid) | TP53 | ||
| kidney | VHL1 | |||
| 16 | kidney | |||
| kidney | PTEN | |||
| 17 | kidney (rhadboid) | FGFR3 | VHL1 | |
| kidney | FGFR3 | VHL1 | ||
| 18 | kidney (sarcomatoid) | VHL1 | JAK3 | |
| kidney (rhadboid) | VHL1 | JAK3 | ||